Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Quinlan

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pharmacology|July 19, 2023
Quantitative Assessment of Ribociclib Exposure-Response Relationship to Justify Dose Regimen in Patients with Advanced Breast CancerYan Ji, Christelle Darstein, Shu Yang, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2015
A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258)Jeffrey R Infante, Ramesh K Ramanathan, Daniel George, et al.
Clinical Pharmacology in Drug Development|October 22, 2025
Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy ParticipantsMatthias Hoch, Wendy Weis, Felix Huth, et al.
Diabetes Technology & Therapeutics|November 28, 2025
A Phase 2 (2a) Randomized Trial of Iscalimab in Adolescents and Young Adults with New-Onset Type 1 DiabetesChantal Mathieu, Michelle Quinlan, Kristina Wagner, et al.
Clinical Pharmacology in Drug Development|July 12, 2022
Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B-Cell Non-Hodgkin's LymphomaAndres Forero-Torres, Jason Claud Chandler, Swaminathan P Iyer, et al.
Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community|January 17, 2023
Identifying research priorities with children, youth, and families: A scoping reviewShokoufeh Modanloo, Quinn Correll, Rhonda Correll, et al.
Clinical Pharmacokinetics|June 4, 2017
Effects of Mild to Severe Hepatic Impairment on the Pharmacokinetics of Sonidegib: A Multicenter, Open-Label, Parallel-Group StudyYves Horsmans, Jocelyn Zhou, Mateva Liudmila, et al.
British Journal of Clinical Pharmacology|September 22, 2022
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumoursXinhui Chen, Nicolas Isambert, Rafael López-López, et al.
AAPS Pharmscitech|September 27, 2017
Evaluating Current Practices in Shelf Life EstimationRobert Capen, David Christopher, Patrick Forenzo, et al.
AAPS Pharmscitech|June 26, 2012
On the shelf life of pharmaceutical productsRobert Capen, David Christopher, Patrick Forenzo, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pharmacology|July 19, 2023
Quantitative Assessment of Ribociclib Exposure-Response Relationship to Justify Dose Regimen in Patients with Advanced Breast CancerYan Ji, Christelle Darstein, Shu Yang, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2015
A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258)Jeffrey R Infante, Ramesh K Ramanathan, Daniel George, et al.
Clinical Pharmacology in Drug Development|October 22, 2025
Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy ParticipantsMatthias Hoch, Wendy Weis, Felix Huth, et al.
Diabetes Technology & Therapeutics|November 28, 2025
A Phase 2 (2a) Randomized Trial of Iscalimab in Adolescents and Young Adults with New-Onset Type 1 DiabetesChantal Mathieu, Michelle Quinlan, Kristina Wagner, et al.
Clinical Pharmacology in Drug Development|July 12, 2022
Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B-Cell Non-Hodgkin's LymphomaAndres Forero-Torres, Jason Claud Chandler, Swaminathan P Iyer, et al.
Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community|January 17, 2023
Identifying research priorities with children, youth, and families: A scoping reviewShokoufeh Modanloo, Quinn Correll, Rhonda Correll, et al.
Clinical Pharmacokinetics|June 4, 2017
Effects of Mild to Severe Hepatic Impairment on the Pharmacokinetics of Sonidegib: A Multicenter, Open-Label, Parallel-Group StudyYves Horsmans, Jocelyn Zhou, Mateva Liudmila, et al.
British Journal of Clinical Pharmacology|September 22, 2022
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumoursXinhui Chen, Nicolas Isambert, Rafael López-López, et al.
AAPS Pharmscitech|September 27, 2017
Evaluating Current Practices in Shelf Life EstimationRobert Capen, David Christopher, Patrick Forenzo, et al.
AAPS Pharmscitech|June 26, 2012
On the shelf life of pharmaceutical productsRobert Capen, David Christopher, Patrick Forenzo, et al.
Pageof 4